%0 Journal Article
%A Faroux, Laurent
%A Lhermusier, Thibault
%A Vincent, Flavien
%A Nombela-Franco, Luis
%A Tchétché, Didier
%A Barbanti, Marco
%A Abdel-Wahab, Mohamed
%A Windecker, Stephan
%A Auffret, Vincent
%A Campanha-Borges, Diego Carter
%A Fischer, Quentin
%A Muñoz-Garcia, Erika
%A Trillo-Nouche, Ramiro
%A Jorgensen, Troels
%A Serra, Vicens
%A Toggweiler, Stefan
%A Tarantini, Giuseppe
%A Saia, Francesco
%A Durand, Eric
%A Donaint, Pierre
%A Gutierrez-Ibanes, Enrique
%A Wijeysundera, Harindra C
%A Veiga, Gabriela
%A Patti, Giuseppe
%A D'Ascenzo, Fabrizio
%A Moreno, Raul
%A Hengstenberg, Christian
%A Chamandi, Chekrallah
%A Asmarats, Lluis
%A Hernandez-Antolin, Rosana
%A Gomez-Hospital, Joan Antoni
%A Cordoba-Soriano, Juan Gabriel
%A Landes, Uri
%A Jimenez-Diaz, Victor Alfonso
%A Cruz-Gonzalez, Ignacio
%A Nejjari, Mohammed
%A Roubille, François
%A Van Belle, Éric
%A Armijo, German
%A Siddiqui, Saifullah
%A Costa, Giuliano
%A Elsaify, Sameh
%A Pilgrim, Thomas
%A le Breton, Hervé
%A Urena, Marina
%A Muñoz-Garcia, Antonio Jesus
%A Sondergaard, Lars
%A Bach-Oller, Montserrat
%A Fraccaro, Chiara
%A Eltchaninoff, Hélène
%A Metz, Damien
%A Tamargo, Maria
%A Fradejas-Sastre, Victor
%A Rognoni, Andrea
%A Bruno, Francesco
%A Goliasch, Georg
%A Santaló-Corcoy, Marcelo
%A Jimenez-Mazuecos, Jesus
%A Webb, John G
%A Muntané-Carol, Guillem
%A Paradis, Jean-Michal
%A Mangieri, Antonio
%A Ribeiro, Henrique Barbosa
%A Campelo-Parada, Francisco
%A Rodés-Cabau, Josep
%T ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement.
%D 2021
%U http://hdl.handle.net/10668/17727
%X Among patients with acute coronary syndrome following transcatheter aortic valve replacement (TAVR), those presenting with ST-segment elevation myocardial infarction (STEMI) are at highest risk. The goal of this study was to determine the clinical characteristics, management, and outcomes of STEMI after TAVR. This was a multicenter study including 118 patients presenting with STEMI at a median of 255 days (interquartile range: 9 to 680 days) after TAVR. Procedural features of STEMI after TAVR managed with primary percutaneous coronary intervention (PCI) were compared with all-comer STEMI: 439 non-TAVR patients who had primary PCI within the 2 weeks before and after each post-TAVR STEMI case in 5 participating centers from different countries. Median door-to-balloon time was higher in TAVR patients (40 min [interquartile range: 25 to 57 min] vs. 30 min [interquartile range: 25 to 35 min]; p = 0.003). Procedural time, fluoroscopy time, dose-area product, and contrast volume were also higher in TAVR patients (p  STEMI after TAVR was associated with very high in-hospital and mid-term mortality. Longer door-to-balloon times and a higher PCI failure rate were observed in TAVR patients, partially due to coronary access issues specific to the TAVR population, and this was associated with poorer outcomes.
%K ST-segment elevation myocardial infarction
%K acute coronary syndrome
%K mortality
%K percutaneous coronary intervention
%K transcatheter aortic valve replacement
%~